SOPs for Nanoparticle Formulation

This SOP outlines the procedure for preparing nanoparticles for nasal drug delivery, which provides a non-invasive route for systemic drug delivery with rapid onset of action.
Click to read the full article.

This SOP outlines the procedure for incorporating targeting ligands (e.g., antibodies, peptides, or folic acid) into nanoparticle formulations for targeted drug delivery applications.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles for ocular drug delivery. These formulations are designed to deliver drugs to the eye with enhanced penetration, controlled release, and reduced systemic side effects.
Click to read the full article.

This SOP outlines the procedure for the preparation of protein-based nanoparticles, which are widely used for drug delivery due to their biocompatibility, biodegradability, and ability to encapsulate both hydrophilic and hydrophobic drugs.
Click to read the full article.

This SOP outlines the procedure for incorporating peptides into nanoparticle formulations. Peptides offer unique advantages for drug delivery, including targeted therapy, enhanced bioavailability, and controlled release.
Click to read the full article.

This SOP outlines the process for preparing nanoparticles specifically designed for gene delivery applications. These nanoparticles are used to carry nucleic acids, such as DNA or RNA, into target cells for therapeutic purposes.
Click to read the full article.

This SOP outlines the process for optimizing the particle size of nanoparticle formulations. Particle size is a critical parameter in determining drug release rate, biodistribution, and therapeutic efficacy.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles for pulmonary drug delivery, where the formulation is optimized for inhalation and targeting the lungs, ensuring rapid drug absorption and minimal systemic exposure.
Click to read the full article.

This SOP describes the procedure for preparing polymeric micelles, which are used in nanoparticle formulations to solubilize poorly water-soluble drugs, improve bioavailability, and provide controlled drug release.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles with controlled release properties, designed to release a drug or therapeutic agent over an extended period.
Click to read the full article.